Volume 32, Issue 151 (March & April 2024)                   J Adv Med Biomed Res 2024, 32(151): 163-167 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sayyadinejad A, Hoseinkhani S. Lichen Striatus with Nail Dystrophy in a 5-Year-Old Girl. J Adv Med Biomed Res 2024; 32 (151) :163-167
URL: http://journal.zums.ac.ir/article-1-7373-en.html
1- Department of dermatology, Vali-e-Asr hospital, School of medicine, Zanjan university of medical Sciences, Zanjan, Iran , asayyadinejad@gmail.com
2- Department of dermatology, Vali-e-Asr hospital, School of medicine, Zanjan university of medical Sciences, Zanjan, Iran
Abstract:   (154 Views)
Lichen striatus (LS) is an uncommon dermatosis. Nail involvement in this disorder is rare.  Diagnosis is usually based on characteristic clinical features include linear papules along Blaschko lines and partial dystrophy of a single nail. LS is self-resolving and gradually improves over several months to years. We report a 5-year- old girl with LS that presented with asymptomatic linear skin colored papules which had extended from left elbow to left index finger nail. Simultaneous lateral nail dystrophy was consistent with nail LS diagnosis. Currently there is no specific treatment for LS and its nail dystrophy. However, prescription of topical steroid and calcineurin inhibitors have been ordered. For the current case, we prescribed topical triamcinolone.
 
Full-Text [PDF 939 kb]   (68 Downloads)    
Type of Study: Case report | Subject: Clinical medicine
Received: 2023/10/18 | Accepted: 2024/02/13 | Published: 2024/03/2

References
1. Krishnegowda S, Reddy SN, Vasudevan P. Lichen striatus with onychodystrophy in an infant. Indian Dermatol Online J. 2015;6(5):333-5. [DOI:10.4103/2229-5178.164489] [PMID] [PMCID]
2. Patrizi A, Neri I, Fiorentini C, et al. Lichen striatus: clinical and laboratory features of 115 children. Pediatr Dermatol. 2004;21(3):197-204. [DOI:10.1111/j.0736-8046.2004.21302.x] [PMID]
3. Herzum A, Viglizz G, Gariazzo L, Ferro J, Gaetano V, Occella C. Lichen striatus after COVID-19. Clin Dermatol. 2022;40(6):744-46. [DOI:10.1016/j.clindermatol.2022.09.006] [PMID] [PMCID]
4. Shepherd V, Lun K,Strutton G. Lichen striatus in an adult following trauma. Astralas J Dermatol.2005;46(1):25-8. [DOI:10.1111/j.1440-0960.2005.00132.x] [PMID]
5. Leung AK, Barankin B. Lichen striatus. Clin Case Rep Rev. 2015;1(1):1-3. [DOI:10.15761/CCRR.1000101] [PMID] [PMCID]
6. Liu ZR, Zhou Y, Liu MX, Wang DG, Wang XQ. Lichen Striatus with nail involvement: Two case reports.Int J Dermatol Venereol.2021;4(4):254-6. [DOI:10.1097/JD9.0000000000000063]
7. Leung AK, Leong KF, Barankin B. Lichen striatus.with nail involvement in a 6 year old boy. Case Rep Pediatr. 2020,2020; 1-3. [DOI:10.1155/2020/1494760] [PMID] [PMCID]
8. Kim M, Jung HY, Eun YS, Cho BK, Park HJ. Nail lichen striatus: report of seven cases and review of the literature. Int J Dermatol. 2015;54(11):1255-60. [DOI:10.1111/ijd.12643] [PMID]
9. Amer A. Bilateral onychodystrophy in a boy with a history of isolated lichen striatus. Cutis. 2014;94(5):E16-E19
10. Inamadar AC,Lichen striatus with nail involvement.Indian J Dermatol Venereol Leprol. 2001;67(4): 197.
11. Tosti A, Peluso A, Misciali C, Cameli N. Nail lichen striatus: clinical features and long-term follow-up of five patients. J Am Acad Dermatol. 1997;36(6):908-13. [DOI:10.1016/S0190-9622(97)80270-8] [PMID]
12. Jakhar D, Kaur I. Onychoscopy of nail involvement in lichen striatus. Indian Dermatol Online J. 2018;9(5):360-361. [DOI:10.4103/idoj.IDOJ_299_17] [PMID] [PMCID]
13. Lorizzo M, Rubin A, Starce M. Nail lichen striatus : Is dermoscopy useful for the diagnosis?.Pediatr Dermatol.2019;36(6):859-63. [DOI:10.1111/pde.13916] [PMID]
14. 14 Cheon DU, RO YS, Kim JE. Treatment of nail lichen striatus with intralesional steroid injection: A case report and literature review.Dermatol Ther.2018;31(6): [DOI:10.1111/dth.12713] [PMID]
15. Romita P, Ettorre G, Bufano T, et al. Lichen striatus successfully treated with oral cyclosporine. Int J Immunopathol pharmacol.2017;30(4):420-22. [DOI:10.1177/0394632017744097] [PMID] [PMCID]

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Advances in Medical and Biomedical Research

Designed & Developed by : Yektaweb